SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vasomedical Inc.
VASO 0.1550.0%10:23 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Antonios Petropoulos who wrote (900)3/22/1998 7:03:00 PM
From: Linda  Read Replies (1) of 1605
 
the hcva reinbursement piece is huge for those of you who may not be in tune with it. First of all vasomedical has huge potential because its non-invasive technique can be used in the non hospital clinic settings.. exactly what the restructuring of health care intends.. out of hospital treatments. In many parts of the USA HCVA is negotiating with states to convert medicaid to managed care.. i.e. more out-patient trends to capitate medical rates.. In addition, vaso's last financial report showed losses due to expansion in abroad... watch this report!..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext